Raymond James & Associates’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-55,978
| Closed | -$711K | – | 3900 |
|
|
2023
Q3 | $711K | Sell |
55,978
-54,604
| -49% | -$749K | ﹤0.01% | 2670 |
|
|
2023
Q2 | $1.57M | Sell |
110,582
-5,825
| -5% | -$81.8K | ﹤0.01% | 2204 |
|
|
2023
Q1 | $1.74M | Sell |
116,407
-41,539
| -26% | -$629K | ﹤0.01% | 2127 |
|
|
2022
Q4 | $2.35M | Sell |
157,946
-62,873
| -28% | -$1.03M | ﹤0.01% | 1890 |
|
|
2022
Q3 | $3.65M | Sell |
220,819
-7,930
| -3% | -$160K | ﹤0.01% | 1592 |
|
|
2022
Q2 | $4.81M | Buy |
228,749
+38,607
| +20% | +$788K | ﹤0.01% | 1425 |
|
|
2022
Q1 | $4.46M | Buy |
190,142
+101,965
| +116% | +$2.5M | ﹤0.01% | 1589 |
|
|
2021
Q4 | $2.4M | Buy |
88,177
+15,594
| +21% | +$417K | ﹤0.01% | 2049 |
|
|
2021
Q3 | $2.06M | Sell |
72,583
-10,792
| -13% | -$329K | ﹤0.01% | 2077 |
|
|
2021
Q2 | $2.51M | Sell |
83,375
-27,153
| -25% | -$801K | ﹤0.01% | 1944 |
|
|
2021
Q1 | $2.81M | Buy |
110,528
+3,182
| +3% | +$81.5K | ﹤0.01% | 1795 |
|
|
2020
Q4 | $2.63M | Buy |
+107,346
| New | +$2.02M | ﹤0.01% | 1728 |
|
|
2020
Q3 | – | Sell |
-15,125
| Closed | -$259K | – | 3650 |
|
|
2020
Q2 | $259K | Buy |
+15,125
| New | +$224K | ﹤0.01% | 3002 |
|
|
2019
Q1 | – | Sell |
-41,898
| Closed | -$1.38M | – | 3682 |
|
|
2018
Q4 | $1.38M | Sell |
41,898
-4,098
| -9% | -$165K | ﹤0.01% | 1879 |
|
|
2018
Q3 | $2.15M | Buy |
45,996
+32,977
| +253% | +$1.51M | ﹤0.01% | 1767 |
|
|
2018
Q2 | $563K | Buy |
13,019
+1,022
| +9% | +$49K | ﹤0.01% | 2597 |
|
|
2018
Q1 | $667K | Sell |
11,997
-557
| -4% | -$30.5K | ﹤0.01% | 2388 |
|
|
2017
Q4 | $671K | Buy |
12,554
+7,660
| +157% | +$361K | ﹤0.01% | 2370 |
|
|
2017
Q3 | $211K | Sell |
4,894
-37,011
| -88% | -$1.76M | ﹤0.01% | 3012 |
|
|
2017
Q2 | $2.53M | Sell |
41,905
-89,374
| -68% | -$5.3M | 0.01% | 1418 |
|
|
2017
Q1 | $9.11M | Sell |
131,279
-9,041
| -6% | -$628K | 0.02% | 721 |
|
|
2016
Q4 | $9.35M | Sell |
140,320
-31,373
| -18% | -$2.04M | 0.02% | 658 |
|
|
2016
Q3 | $11.4M | Buy |
171,693
+11,064
| +7% | +$757K | 0.03% | 545 |
|
|
2016
Q2 | $11.6M | Buy |
160,629
+10,063
| +7% | +$692K | 0.04% | 483 |
|
|
2016
Q1 | $9.73M | Buy |
150,566
+33,581
| +29% | +$2.23M | 0.03% | 530 |
|
|
2015
Q4 | $8.38M | Buy |
116,985
+1,251
| +1% | +$92.5K | 0.03% | 590 |
|
|
2015
Q3 | $8.89M | Buy |
115,734
+1,435
| +1% | +$116K | 0.04% | 528 |
|
|
2015
Q2 | $8.47M | Buy |
114,299
+52,916
| +86% | +$3.81M | 0.03% | 581 |
|
|
2015
Q1 | $4.45M | Buy |
61,383
+31,298
| +104% | +$2.18M | 0.02% | 803 |
|
|
2014
Q4 | $1.99M | Buy |
30,085
+10,631
| +55% | +$649K | 0.01% | 1164 |
|
|
2014
Q3 | $1.07M | Sell |
19,454
-8,550
| -31% | -$485K | 0.01% | 1460 |
|
|
2014
Q2 | $1.63M | Buy |
28,004
+4,384
| +19% | +$258K | 0.01% | 1211 |
|
|
2014
Q1 | $1.46M | Buy |
23,620
+5,117
| +28% | +$298K | 0.01% | 1208 |
|
|
2013
Q4 | $988K | Buy |
+18,503
| New | +$993K | 0.01% | 1339 |
|
Other funds holding MD
Raymond James & Associates's MD Position: Q4 2023 in Review
Raymond James & Associates sold out of Pediatrix Medical (MD) in Q4 2023, closing a stake of 55,978 shares — an estimated $711K sold.
Raymond James & Associates first reported a position in MD in Q4 2013 and held it in 34 quarters. The position peaked at $11.6M in Q2 2016. 223 funds tracked by Wall St. Rank hold MD as of Q4 2023.
- Raymond James & Associates reported no remaining Pediatrix Medical position as of Q4 2023 after selling out during the quarter.
- Raymond James & Associates sold 55,978 Pediatrix Medical shares in Q4 2023, an estimated $711K.
- Raymond James & Associates first reported a position in Pediatrix Medical in Q4 2013 and held it in 34 quarters.
- Raymond James & Associates's Pediatrix Medical position peaked at $11.6M in Q2 2016.
- 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2023.
Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.